The current valuation score of Innoviva Inc is 7.66, ranking 92 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 2.88, which is 1667.52% below the recent high of 50.90 and 898.50% above the recent low of -22.99.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.